November 14, 2024
Inotiv is incredibly pleased to announce that we’ve received a $1.8 million dollar grant to develop a novel chronic kidney disease (CKD) in vivo model that can bridge the gap between current translational models and human renal research. Translational models of CKD are important tools in understanding complex disease pathways and how potential therapeutics can mitigate or even cure kidney disease.
